These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 32485534)
1. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity. Soliman AM; Ghorab MM; Bua S; Supuran CT Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534 [TBL] [Abstract][Full Text] [Related]
2. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors. Ghorab MM; Soliman AM; Bua S; Supuran CT Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104 [TBL] [Abstract][Full Text] [Related]
3. Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors. Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Petreni A; Allam RM; El Diwani HI; Supuran CT Eur J Med Chem; 2022 Jan; 228():114004. PubMed ID: 34847409 [TBL] [Abstract][Full Text] [Related]
4. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies. Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134 [TBL] [Abstract][Full Text] [Related]
5. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors. El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526 [TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Szafrański K; Vullo D; Supuran CT Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761 [TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII. George RF; Said MF; Bua S; Supuran CT Bioorg Chem; 2020 Jan; 95():103514. PubMed ID: 31887473 [TBL] [Abstract][Full Text] [Related]
9. 1,3-Diaryl Triazenes Incorporating Disulfonamides Show Both Antiproliferative Activity and Effective Inhibition of Tumor-associated Carbonic Anhydrases IX and XII. Lolak N; Akocak S; Petreni A; Budak Y; Bozgeyik E; Gurdere MB; Ceylan M; Supuran CT Anticancer Agents Med Chem; 2024; 24(10):755-763. PubMed ID: 38362678 [TBL] [Abstract][Full Text] [Related]
10. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607 [TBL] [Abstract][Full Text] [Related]
11. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII. SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors. Yamali C; Gul HI; Ece A; Bua S; Angeli A; Sakagami H; Sahin E; Supuran CT Bioorg Chem; 2019 Nov; 92():103222. PubMed ID: 31499260 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents. Hao S; Cheng X; Wang X; An R; Xu H; Guo M; Li C; Wang Y; Hou Z; Guo C Bioorg Chem; 2020 Nov; 104():104237. PubMed ID: 32911194 [TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties. Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360 [TBL] [Abstract][Full Text] [Related]
15. Insertion of metal carbenes into the anilinic N-H bond of unprotected aminobenzenesulfonamides delivers low nanomolar inhibitors of human carbonic anhydrase IX and XII isoforms. Sharonova T; Paramonova P; Kalinin S; Bunev A; Gasanov RЕ; Nocentini A; Sharoyko V; Tennikova TB; Dar'in D; Supuran CT; Krasavin M Eur J Med Chem; 2021 Jun; 218():113352. PubMed ID: 33774343 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, molecular modelling and QSAR study of new Said MF; George RF; Petreni A; Supuran CT; Mohamed NM J Enzyme Inhib Med Chem; 2022 Dec; 37(1):701-717. PubMed ID: 35168458 [TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996 [TBL] [Abstract][Full Text] [Related]
19. Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities. Elbadawi MM; Eldehna WM; Nocentini A; Abo-Ashour MF; Elkaeed EB; Abdelgawad MA; Alharbi KS; Abdel-Aziz HA; Supuran CT; Gratteri P; Al-Sanea MM Eur J Med Chem; 2021 Jun; 218():113360. PubMed ID: 33773285 [TBL] [Abstract][Full Text] [Related]
20. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform. Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]